Publication | Open Access

Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability

Compound FlexibilityMicrosomal StabilityMedicineGynecologyPharmacotherapySelective V1a AntagonistPharmacologyDrug Discovery